Supplemented zinc does not alter mood in healthy older European adults--a randomised placebo-controlled trial: the Zenith study

Public Health Nutr. 2011 May;14(5):882-8. doi: 10.1017/S1368980010002764. Epub 2011 Jan 28.

Abstract

Objective: Older people are vulnerable to zinc deficiency, which may impact upon their mood. This randomised, placebo-controlled, double-blind intervention study aimed to investigate the effect of oral zinc gluconate supplementation (15 mg/d; 30 mg/d; and placebo) on subjective mood (affect) in older Europeans.

Subjects: Healthy volunteers (n 387) aged 55-87 years were recruited.

Setting: Volunteers in Rome (Italy; n 108) and Grenoble (France; n 91) were aged 70-87 years and those in Coleraine (Northern Ireland; n 93) and Clermont-Ferrand (France; n 95) were aged 55-70 years.

Design: Mood was measured using the Positive and Negative Affect Scale on four occasions per day over 4 d at baseline, 3 and 6 months post-intervention.

Results: Mixed ANOVA indicated that neither positive nor negative affect altered in response to zinc (15 mg/d or 30 mg/d) compared to placebo in either the 55-70 years or the ≥70 years age group.

Conclusions: These results suggest that zinc does not benefit mood in healthy older people.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Affect / drug effects*
  • Aged
  • Aged, 80 and over
  • Dietary Supplements*
  • Double-Blind Method
  • Europe
  • Female
  • Humans
  • Male
  • Middle Aged
  • Trace Elements / administration & dosage
  • Trace Elements / blood
  • Trace Elements / deficiency
  • Trace Elements / pharmacology*
  • Zinc / administration & dosage
  • Zinc / blood
  • Zinc / deficiency
  • Zinc / pharmacology*

Substances

  • Trace Elements
  • Zinc